HDAC6 and neurodegenerative disease: Further emphasizing the therapeutic potential of HDAC6 inhibitors are results demonstrating that loss of HDAC6 expression/activity is also neuroprotective in other neurodegenerative diseases, including AD, Huntington’s disease and amyotrophic lateral sclerosis [46-48].